Trial of MiStent Compared to Xience in Japan — DESSOLVEJ  

Coronary (Artery); Disease Clinical Trial

Official title: Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MT005) for Revascularization of Coronary Arteries

Status Active, not recruiting

Clinical Trial Summary

To compare the MT005 (MiStent) with the XIENCE with respect to target lesion failure (TLF) at 12 months in a non-inferiority trial in a "real world" patient population and to confirm that the domestic extrapolation of the DESSOLVE III study results is valid.

Clinical Trial Description

This is a prospective, randomized, 1:1 balanced, controlled, double-blind, multi-center study comparing clinical outcomes at 12 months between MT005 (MiStent) and XIENCE in an all-comers population, including patients with symptomatic coronary artery disease including patients with chronic stable angina, silent ischemia, and acute coronary syndromes, who qualify for percutaneous coronary interventions. ;

Related Conditions & MeSH terms

• Coronary (Artery); Disease
• Coronary Artery Disease
• Coronary Disease

• NCT number: NCT02972671
• Study type: Interventional
• Source: Micell Technologies
• Status: Active, not recruiting
• Phase: N/A
• Start date: November 28, 2016
• Completion date: April 30, 2022